KOMET-008: A phase 1 study to determine the safety and tolerability of ziftomenib combinations for the treatment of KMT2A-rearranged or NPM1-mutant relapsed/refractory acute myeloid leukemia Meeting Abstract
| Authors: | Goldberg, A. D.; Corum, D.; Ahsan, J.; Nie, K.; Kozlek, T.; Leoni, M.; Dale, S. |
| Abstract Title: | KOMET-008: A phase 1 study to determine the safety and tolerability of ziftomenib combinations for the treatment of KMT2A-rearranged or NPM1-mutant relapsed/refractory acute myeloid leukemia |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1553 |
| Language: | English |
| ACCESSION: | WOS:001159306706024 |
| DOI: | 10.1182/blood-2023-190475 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
